259 related articles for article (PubMed ID: 27456754)
1. 5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
Pavlova O; Fraitag S; Hohl D
J Invest Dermatol; 2016 Dec; 136(12):2453-2461. PubMed ID: 27456754
[TBL] [Abstract][Full Text] [Related]
2. Reduced H3K27me3 Expression Is Common in Nodular Melanomas of Childhood Associated With Congenital Melanocytic Nevi But Not in Proliferative Nodules.
Busam KJ; Shah KN; Gerami P; Sitzman T; Jungbluth AA; Kinsler V
Am J Surg Pathol; 2017 Mar; 41(3):396-404. PubMed ID: 27849631
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
Lee JJ; Vilain RE; Granter SR; Hu NR; Bresler SC; Xu S; Frank AH; Mihm MC; Saw RP; Fletcher CD; Scolyer RA; Murphy GF; Lian CG
J Cutan Pathol; 2017 Mar; 44(3):249-255. PubMed ID: 28032662
[TBL] [Abstract][Full Text] [Related]
4. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases.
Phadke PA; Rakheja D; Le LP; Selim MA; Kapur P; Davis A; Mihm MC; Hoang MP
Am J Surg Pathol; 2011 May; 35(5):656-69. PubMed ID: 21436676
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of genome-wide 5-methylcytosine level is an epigenetic feature of cutaneous malignant melanomas.
Micevic G; Theodosakis N; Taube JM; Bosenberg MW; Rodić N
Melanoma Res; 2017 Apr; 27(2):85-96. PubMed ID: 27997431
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
Siref AB; Huynh CAT; Balzer BL; Frishberg DP; Essner R; Shon W
J Cutan Pathol; 2019 Apr; 46(4):261-266. PubMed ID: 30632191
[TBL] [Abstract][Full Text] [Related]
7. PRAME Immunohistochemical Expression and TERT Promoter Mutational Analysis as Ancillary Diagnostic Tools for Differentiating Proliferative Nodules From Melanoma Arising in Congenital Nevi.
Boutko A; Hagstrom M; Lampley N; Roth A; Olivares S; Dhillon S; Fumero-Velázquez M; Benton S; Zhao J; Zhang B; Dittmann D; Asadbeigi S; Busam KJ; Gerami P
Am J Dermatopathol; 2023 Jul; 45(7):437-447. PubMed ID: 37338065
[TBL] [Abstract][Full Text] [Related]
8. Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.
Larson AR; Dresser KA; Zhan Q; Lezcano C; Woda BA; Yosufi B; Thompson JF; Scolyer RA; Mihm MC; Shi YG; Murphy GF; Lian CG
Mod Pathol; 2014 Jul; 27(7):936-44. PubMed ID: 24390216
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry Imaging Can Distinguish on a Proteomic Level Between Proliferative Nodules Within a Benign Congenital Nevus and Malignant Melanoma.
Lazova R; Yang Z; El Habr C; Lim Y; Choate KA; Seeley EH; Caprioli RM; Yangqun L
Am J Dermatopathol; 2017 Sep; 39(9):689-695. PubMed ID: 28248717
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
Rodić N; Zampella J; Sharma R; Burns KH; Taube JM
J Cutan Pathol; 2015 Nov; 42(11):807-14. PubMed ID: 26239102
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of tubulin β-3 and 5 hydroxy-methyl cytosine as diagnostic and prognostic markers in malignant melanoma.
Katarzyna L; Kyriakos O; Linda V; Ingrid S; Petra W; Karin Ö
Ann Diagn Pathol; 2024 Oct; 72():152332. PubMed ID: 38776734
[TBL] [Abstract][Full Text] [Related]
12. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
[TBL] [Abstract][Full Text] [Related]
13. Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi.
Fan Y; Lee S; Wu G; Easton J; Yergeau D; Dummer R; Vogel P; Kirkwood JM; Barnhill RL; Pappo A; Bahrami A
J Invest Dermatol; 2016 Jan; 136(1):339-342. PubMed ID: 26763461
[No Abstract] [Full Text] [Related]
14. Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
Lee JJ; Cook M; Mihm MC; Xu S; Zhan Q; Wang TJ; Murphy GF; Lian CG
Oncotarget; 2015 Nov; 6(35):37995-8004. PubMed ID: 26462027
[TBL] [Abstract][Full Text] [Related]
15. Neonatal giant congenital nevi with proliferative nodules: a clinicopathologic study and literature review of neonatal melanoma.
Leech SN; Bell H; Leonard N; Jones SL; Geurin D; McKee PH; Lawrence CM
Arch Dermatol; 2004 Jan; 140(1):83-8. PubMed ID: 14732664
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 and D3 expression in melanocytic skin lesions.
Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
[TBL] [Abstract][Full Text] [Related]
17. The relationship between melanocytic nevi and malignant melanoma.
Friedman RJ; Rigel DS; Heilman ER
Dermatol Clin; 1988 Apr; 6(2):249-56. PubMed ID: 3378371
[TBL] [Abstract][Full Text] [Related]
18. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?
Xavier-Junior JCC; Ocanha-Xavier JP
Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551
[TBL] [Abstract][Full Text] [Related]
19. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families.
Novakovic B; Clark WH; Fears TR; Fraser MC; Tucker MA
J Am Acad Dermatol; 1995 Oct; 33(4):631-6. PubMed ID: 7673498
[TBL] [Abstract][Full Text] [Related]
20. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Lian CG; Xu Y; Ceol C; Wu F; Larson A; Dresser K; Xu W; Tan L; Hu Y; Zhan Q; Lee CW; Hu D; Lian BQ; Kleffel S; Yang Y; Neiswender J; Khorasani AJ; Fang R; Lezcano C; Duncan LM; Scolyer RA; Thompson JF; Kakavand H; Houvras Y; Zon LI; Mihm MC; Kaiser UB; Schatton T; Woda BA; Murphy GF; Shi YG
Cell; 2012 Sep; 150(6):1135-46. PubMed ID: 22980977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
